Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Dyne Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 127 | 118 | −9 |
| Shares | 54.6M | 59.2M | +4.56M (+8.4%) |
| Value | $628.7M | $665.9M | +$37.1M (+5.9%) |
New holders (15)
Institutions that held Dyne Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| VR Adviser, LLC | 2,173,913 | $24.5M | 3.91% |
| Armistice Capital, LLC | 912,000 | $10.3M | 0.26% |
| Polar Capital Holdings Plc | 500,000 | $5.63M | 0.04% |
| Sofinnova Investments, Inc. | 441,048 | $4.96M | 0.33% |
| Woodline Partners LP | 382,576 | $4.30M | 0.05% |
| Rafferty Asset Management, LLC | 117,264 | $1.32M | 0.01% |
| Acuta Capital Partners, LLC | 73,000 | $821.3K | 0.56% |
| Profund Advisors LLC | 21,662 | $243.7K | 0.01% |
| Cornercap Investment Counsel Inc | 21,235 | $238.9K | 0.04% |
| AQR Capital Management LLC | 20,169 | $226.9K | 0.00% |
| American Century Companies Inc | 20,018 | $225.2K | 0.00% |
| Corton Capital Inc. | 13,133 | $147.7K | 0.07% |
| State Board of Administration of Florida Retirement System | 12,065 | $135.7K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 5,287 | $59.5K | 0.00% |
| EverSource Wealth Advisors, LLC | 90 | $1.01K | 0.00% |
Sold out (24)
Institutions that held Dyne Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.